Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 25,661,000 | 23,838,000 | 24,035,000 | 18,899,000 | 14,516,000 |
| Cost of Goods | 9,984,000 | 9,736,000 | 9,932,000 | 6,996,000 | 4,157,000 |
| Gross Profit | 15,677,000 | 14,102,000 | 14,103,000 | 11,903,000 | 10,359,000 |
| Operating Expenses | 6,276,000 | 11,111,000 | 7,956,000 | 6,297,000 | 5,670,000 |
| Operating Income | 9,401,000 | 2,991,000 | 6,147,000 | 5,606,000 | 4,689,000 |
| Other Income | -351,000 | 836,000 | 1,696,000 | 1,343,000 | 1,003,000 |
| Pre-tax Income | 9,050,000 | 3,827,000 | 7,843,000 | 6,949,000 | 5,692,000 |
| Income Tax | 1,172,000 | 249,000 | -328,000 | 1,123,000 | 808,000 |
| Net Income Continuous | 7,879,000 | 3,578,000 | 8,171,000 | 5,825,000 | 4,885,000 |
| Net Income Discontinuous | -9,000 | -186,000 | -13,000 | -236,000 | 1,000 |
| Minority Interests | 6,000 | -2,000 | 12,000 | 26,000 | 9,000 |
| Net Income | $7,864,000 | $3,393,000 | $8,147,000 | $5,563,000 | $4,877,000 |
| EPS Basic Total Ops | 1.40 | 0.61 | 1.45 | 0.99 | 0.87 |
| EPS Basic Continuous Ops | 1.40 | 0.64 | 1.45 | 1.04 | 0.87 |
| EPS Basic Discontinuous Ops | 0.00 | -0.04 | 0.00 | -0.04 | 0.00 |
| EPS Diluted Total Ops | 1.37 | 0.59 | 1.42 | 0.98 | 0.86 |
| EPS Diluted Continuous Ops | 1.37 | 0.62 | 1.43 | 1.02 | 0.86 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.04 | 0.00 | -0.04 | 0.00 |
| EBITDA(a) | $10,588,000 | $4,326,000 | $7,488,000 | $6,914,000 | $5,896,000 |